News and Resources
MHRP, WRAIR Begin New Phase 2 Clinical Trial of Ebola Vaccine Regimens
The Walter Reed Army Institute of Research (WRAIR) today announced the initiation of a Phase 2 clinical trial to evaluate the safety and immunogenicity of a prime-boost Ebola vaccine regimen in both healthy and HIV-infected study volunteers. This study includes two vaccine candidates, Ad26.ZEBOV from Crucell Holland B.V., one of…